Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 22

Sort by

Sort Order Select

Journal Articles

Pilot Study of Telmisartan (Micardis) for Prevention of Acute Graft Vs. Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation: Interim Analysis

Sujatha Iyengar, PhD, Scott D. Rowley, MD, Caixin Zhan, Michele L. Donato, MD, Themba Nyirenda, PhD, David H. Schwartz, MD PhD

Blood (2019) 134 (Supplement_1): 4546.

https://doi.org/10.1182/blood-2019-129378

Published: 2019

Journal Articles

Evaluation of Biomarkers As Predictors of Blinatumomab Toxicity and Real-World Management of Blinatumomab Toxicity in B-Acute Lymphoblastic Leukemia Patients

Amber C. King, PharmD, BCOP, Jae H. Park, MD, Mark B. Geyer, MD

Blood (2019) 134 (Supplement_1): 3887.

https://doi.org/10.1182/blood-2019-128506

Published: 2019

Journal Articles

Development of Novel Anti-CD10 Target Modules for Redirection of Universal CAR T Cells Against CD10-Positive Malignancies

Anja Feldmann, PhD, Stefanie Koristka, PhD, Claudia Arndt, PhD, Liliana Raquel Loureiro, PhD, Ralf Bergmann, PhD, Nicole Berndt, PhD, Anja Hoffmann, Justyna Jureczek, Nicola Mitwasi, Martin Bornhaeuser, MD, Václav Hořejší, Michael Bachmann, MD

Blood (2019) 134 (Supplement_1): 5612.

https://doi.org/10.1182/blood-2019-128193

Published: 2019

Journal Articles

Development of Target Modules for Early and Late Stage Cancer Treatment Using Switchable Unicar T Cell Therapy

Liliana Raquel Loureiro, PhD, Anja Feldmann, PhD, Ralf Bergmann, PhD, Nicole Berndt, PhD, Stefanie Koristka, PhD, Nicola Mitwasi, Anja Hoffmann, Justyna Jureczek, Martin Bornhaeuser, MD, Michael Bachmann, MD, Claudia Arndt, PhD

Blood (2019) 134 (Supplement_1): 5613.

https://doi.org/10.1182/blood-2019-128249

Published: 2019

Journal Articles

Targeting the FMS-like Tyrosin Kinase 3 with the Unicar System: Preclinical Comparison of Murine and Humanized Single-Chain Variable Fragment-Based Targeting Modules

Frederick Fasslrinner, MD, Claudia Arndt, PhD, Anja Feldmann, PhD, Stefanie Koristka, PhD, Liliana Raquel Loureiro, PhD, Marc Schmitz, MD, Gundram Jung, MD, Martin Bornhaeuser, MD, Michael Bachmann, MD

Blood (2019) 134 (Supplement_1): 5614.

https://doi.org/10.1182/blood-2019-124279

Published: 2019

Journal Articles

Late-Stage Preclinical Characterization of Switchable CD123-Specific CAR-T for Treatment of Acute Leukemia

Simon Loff, MSc, Jan-Erik Meyer, Dipl. Biol., Josephine Dietrich, Msc, Johannes Spehr, PhD, Riewaldt Julia, PhD, Malte von Bonin, MD, Cordula Gründer, PhD, Kristin Franke, PhD, Anja Feldmann, PhD, Michael Bachmann, MD, Gerhard Ehninger, MD, Armin Ehninger, PhD, Marc Cartellieri, PhD

Blood (2018) 132 (Supplement 1): 964.

https://doi.org/10.1182/blood-2018-99-113288

Published: 2018

Journal Articles

High Dose Telmisartan for Prevention of Acute Graft Vs. Host Disease

David H. Schwartz, MD/ PhD, Sujatha Iyengar, PhD, Michele L Donato, MD FACP, Alan P Skarbnik, MD, David H. Vesole, MD, Scott D. Rowley, MD FACP, Themba L Nyirenda, PhD

Blood (2016) 128 (22): 5783.

https://doi.org/10.1182/blood.V128.22.5783.5783

Published: 2016

Journal Articles

Improved Killing of AML Blasts By Dual-Targeting of CD123 and CD33 Via Unitarg a Novel Antibody-Based Modular T Cell Retargeting System

Claudia Arndt, PhD, Anja Feldmann, PhD, Stefanie Koristka, MSc, Marc Cartellieri, PhD, Malte von Bonin, MD, Armin Ehninger, PhD, Martin Bornhäuser, MD, Gerhard Ehninger, Michael P Bachmann, Prof.

Blood (2015) 126 (23): 2565.

https://doi.org/10.1182/blood.V126.23.2565.2565

Published: 2015

Journal Articles

Unicar: A Novel Modular Retargeting Platform Technology for CAR T Cells

Marc Cartellieri, PhD, Simon Loff, MSc, Malte von Bonin, MD, Elham P. Bejestani, MSc, Armin Ehninger, PhD, Anja Feldmann, PhD, Stefanie Koristka, MSc, Claudia Arndt, PhD, Gerhard Ehninger, Prof., Michael P Bachmann, Prof.

Blood (2015) 126 (23): 5549.

https://doi.org/10.1182/blood.V126.23.5549.5549

Published: 2015

Journal Articles

Alemtuzumab-Cyclosporine Versus Tacrolimus-Methotrexate-Sirolimus for Graft-Versus-Host Disease Prophylaxis in Reduced Intensity Allogeneic Hematopoietic Stem Cell Transplantation from Unrelated Donors: Final Results of a Randomized Trial

Blood (2015) 126 (23): 65.

https://doi.org/10.1182/blood.V126.23.65.65

Published: 2015

Journal Articles

Infectious Complications After Unrelated Donor Allogeneic Hematopoietic Cell Transplantation With Or Without Alemtuzumab Based In Vivo Lymphocyte Depletion

Brian C. Shaffer, MD, Andrew Flynn, David Moorshead, Zach Powell, Jennifer Hsu, RN, Rachel B Salit, MD, Frances T. Hakim, PhD, Ronald E. Gress, MD, Michael Bishop, MD, Juan Gea-Banacloche, MD, Steven Z. Pavletic, MD

Blood (2013) 122 (21): 4580.

https://doi.org/10.1182/blood.V122.21.4580.4580

Published: 2013

Journal Articles

Influence of Graft Versus-Host Disease Prophylaxis Regimen On T-Cell Repertoire Diversity Following Reduced-Intensity HLA-Matched Unrelated Donor Allogeneic Hematopoietic Stem Cell Transplantation.

Rachel B. Salit, MD, Frances T. Hakim, PhD, Michael R. Bishop, MD, Thea M. Friedman, PhD, Robert Korngold, PhD, Kira Goldgirsh, PhD, Sarfraz Memon, MD, Seth M. Steinberg, PhD, David Liewehr, MS, Daniel Peaceman, BS, Jennifer Wilder, RN, Kelly Bryant, RN, Daniel H. Fowler, MD, Juan Gea-Banacloche, MD, Ronald E. Gress, MD, Steven Z. Pavletic, MD

Blood (2012) 120 (21): 3054.

https://doi.org/10.1182/blood.V120.21.3054.3054

Published: 2012

Journal Articles

Pilot Randomized Trial Comparing the Effects of Alemtuzumab and Cyclosporine Versus Tacrolimus, Methotrexate and Sirolimus on Graft Versus Host Disease Prevention, Engraftment and Immune Reconstitution After Reduced Intensity Unrelated Donor Transplantation.

Rachel B. Salit, MD, Steven Z. Pavletic, MD, Daniel H. Fowler, MD, Jennifer Wilder, RN, Kelly Bryant, RN, Seth M. Steinberg, PhD, Frances T. Hakim, PhD, Michael R. Bishop, MD

Blood (2010) 116 (21): 1245.

https://doi.org/10.1182/blood.V116.21.1245.1245

Published: 2010

Journal Articles

Use of Targeted Lymphocyte Depletion as a Personalized Approach to Improve Engraftment and Disease Control Following Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation Using HLA-Matched Unrelated Donors

Rachel B. Salit, MD, Steven Z. Pavletic, MD, Daniel H. Fowler, MD, Jennifer Wilder, RN, Kelly Bryant, RN, Seth M. Steinberg, PhD, Frances T. Hakim, PhD, Michael R. Bishop, MD

Blood (2010) 116 (21): 3530.

https://doi.org/10.1182/blood.V116.21.3530.3530

Published: 2010

Journal Articles

Tropomodulin 1-null mice have a mild spherocytic elliptocytosis with appearance of Tropomodulin 3 in red blood cells and disruption of the membrane skeleton

Jeannette D. Moyer, Roberta B. Nowak, Nancy E. Kim, Sandra K. Larkin, Luanne L. Peters, John Hartwig, Frans A. Kuypers, Velia M. Fowler

Blood (2010) 116 (14): 2590–2599.

https://doi.org/10.1182/blood-2010-02-268458

Published: 2010

Includes: Supplemental data

Journal Articles

CD137 agonist antibody prevents cancer recurrence: contribution of CD137 on both hematopoietic and nonhematopoietic cells

Hidehiko Narazaki, Yuwen Zhu, Liqun Luo, Gefeng Zhu, Lieping Chen

Blood (2010) 115 (10): 1941–1948.

https://doi.org/10.1182/blood-2008-12-192591

Published: 2010

Includes: Supplemental data

Journal Articles

Factors That Influence the Homo- and Hetero-Oligomerization of the Leukocyte Integrin Transmembrane Domains

Lisa M. Span, Gevorg Grigoryan, Joel S. Bennett, MD, William F. DeGrado

Blood (2008) 112 (11): 3556.

https://doi.org/10.1182/blood.V112.11.3556.3556

Published: 2008

Journal Articles

Characterization of the Interaction between Cleaved High Molecular Weight Kininogen (HKa) and Tropomyosin (TM) on Endothelial Cells.

Xiaoping Qi, M.D., Ph.D., Keith R. McCrae, M.D.

Blood (2004) 104 (11): 3918.

https://doi.org/10.1182/blood.V104.11.3918.3918

Published: 2004

Journal Articles

Effect of Wine Phenolics and Their Analogs on Suppression of Tissue Factor Induction in Mononuclear Cells.

Gurjeet Kaur, Ph.D., Usha Pendurthi, Ph.D.

Blood (2004) 104 (11): 1866.

https://doi.org/10.1182/blood.V104.11.1866.1866

Published: 2004

Journal Articles

Promoter hypermethylation of cancer-related genes: a strong independent prognostic factor in acute lymphoblastic leukemia

Jose Roman-Gomez, Antonio Jimenez-Velasco, Juan A. Castillejo, Xabier Agirre, Manuel Barrios, German Navarro, Francisco J. Molina, Maria J. Calasanz, Felipe Prosper, Anabel Heiniger, Antonio Torres

Blood (2004) 104 (8): 2492–2498.

https://doi.org/10.1182/blood-2004-03-0954

Published: 2004

NARROW

Pilot Study of Telmisartan (Micardis) for Prevention of Acute Graft Vs. Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation: Interim Analysis

Evaluation of Biomarkers As Predictors of Blinatumomab Toxicity and Real-World Management of Blinatumomab Toxicity in B-Acute Lymphoblastic Leukemia Patients

Development of Novel Anti-CD10 Target Modules for Redirection of Universal CAR T Cells Against CD10-Positive Malignancies

Development of Target Modules for Early and Late Stage Cancer Treatment Using Switchable Unicar T Cell Therapy

Targeting the FMS-like Tyrosin Kinase 3 with the Unicar System: Preclinical Comparison of Murine and Humanized Single-Chain Variable Fragment-Based Targeting Modules

Late-Stage Preclinical Characterization of Switchable CD123-Specific CAR-T for Treatment of Acute Leukemia

High Dose Telmisartan for Prevention of Acute Graft Vs. Host Disease

Improved Killing of AML Blasts By Dual-Targeting of CD123 and CD33 Via Unitarg a Novel Antibody-Based Modular T Cell Retargeting System

Unicar: A Novel Modular Retargeting Platform Technology for CAR T Cells

Alemtuzumab-Cyclosporine Versus Tacrolimus-Methotrexate-Sirolimus for Graft-Versus-Host Disease Prophylaxis in Reduced Intensity Allogeneic Hematopoietic Stem Cell Transplantation from Unrelated Donors: Final Results of a Randomized Trial

Infectious Complications After Unrelated Donor Allogeneic Hematopoietic Cell Transplantation With Or Without Alemtuzumab Based In Vivo Lymphocyte Depletion

Influence of Graft Versus-Host Disease Prophylaxis Regimen On T-Cell Repertoire Diversity Following Reduced-Intensity HLA-Matched Unrelated Donor Allogeneic Hematopoietic Stem Cell Transplantation.

Pilot Randomized Trial Comparing the Effects of Alemtuzumab and Cyclosporine Versus Tacrolimus, Methotrexate and Sirolimus on Graft Versus Host Disease Prevention, Engraftment and Immune Reconstitution After Reduced Intensity Unrelated Donor Transplantation.

Use of Targeted Lymphocyte Depletion as a Personalized Approach to Improve Engraftment and Disease Control Following Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation Using HLA-Matched Unrelated Donors

Tropomodulin 1-null mice have a mild spherocytic elliptocytosis with appearance of Tropomodulin 3 in red blood cells and disruption of the membrane skeleton

CD137 agonist antibody prevents cancer recurrence: contribution of CD137 on both hematopoietic and nonhematopoietic cells

Factors That Influence the Homo- and Hetero-Oligomerization of the Leukocyte Integrin Transmembrane Domains

Characterization of the Interaction between Cleaved High Molecular Weight Kininogen (HKa) and Tropomyosin (TM) on Endothelial Cells.

Effect of Wine Phenolics and Their Analogs on Suppression of Tissue Factor Induction in Mononuclear Cells.

Promoter hypermethylation of cancer-related genes: a strong independent prognostic factor in acute lymphoblastic leukemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only